1 |
1242 |
(5Z)-7-Oxozeaenol |
5Z-7-Oxozeaenol, LL-Z1640-2 |
TAK1 |
Other, kinases |
9863776 |
945 |
266 |
2 |
179 |
5-Fluorouracil |
5-FU |
Antimetabolite (DNA & RNA) |
Other |
3385 |
968 |
266 |
3 |
86 |
A-443654 |
KIN001-139 |
AKT1, AKT2, AKT3 |
PI3K/MTOR signaling |
10172943 |
425 |
266 |
4 |
55 |
A-770041 |
KIN001-111 |
LCK, FYN |
Other, kinases |
9549184 |
426 |
266 |
5 |
1001 |
AICA Ribonucleotide |
AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide |
AMPK agonist |
Metabolism |
65110 |
872 |
266 |
6 |
171 |
AKT inhibitor VIII |
Akti-1/2 |
AKT1, AKT2, AKT3 |
PI3K/MTOR signaling |
10196499 |
934 |
266 |
7 |
228 |
AKT inhibitor VIII |
Akti-1/2, KIN001-102 |
AKT1, AKT2, AKT3 |
PI3K/MTOR signaling |
10196499 |
979 |
266 |
8 |
272 |
AR-42 |
HDAC-42, AR 42, AR42 |
HDAC1 |
Chromatin histone acetylation |
6918848 |
965 |
266 |
9 |
207 |
AS601245 |
|
JNK1, JNK2, JNK2 |
JNK and p38 signaling |
10109823 |
925 |
266 |
10 |
224 |
AS605240 |
KIN001-173, AS-605240 |
PI3Kgamma |
PI3K/MTOR signaling |
5289247 |
975 |
266 |
11 |
219 |
AT-7519 |
AT7519 |
CDK1, CDK2, CDK4, CDK6, CDK9 |
Cell cycle |
11338033 |
976 |
266 |
12 |
29 |
AZ628 |
AZ-628, AZ 628 |
BRAF |
ERK MAPK signaling |
11676786 |
428 |
266 |
13 |
156 |
AZD6482 |
AZD 6482, AZD-6482, AK-55409 |
PI3Kbeta |
PI3K/MTOR signaling |
44137675 |
933 |
266 |
14 |
1066 |
AZD6482 |
AZD 6482, AZD-6482, AK-55409 |
PI3Kbeta |
PI3K/MTOR signaling |
44137675 |
931 |
266 |
15 |
1022 |
AZD7762 |
AZD-7762, AZD 7762 |
CHEK1, CHEK2 |
Cell cycle |
11152667 |
881 |
266 |
16 |
1059 |
AZD8055 |
AZD-8055 |
MTORC1, MTORC2 |
PI3K/MTOR signaling |
25262965 |
870 |
266 |
17 |
1032 |
Afatinib |
BIBW2992, Tovok, Gilotrif |
ERBB2, EGFR |
EGFR signaling |
10184653 |
881 |
266 |
18 |
1377 |
Afatinib |
BIBW2992, Tovok, Gilotrif |
ERBB2, EGFR |
EGFR signaling |
10184653 |
944 |
266 |
19 |
281 |
Alectinib |
CH5424802, CH 542802, Alecensa |
ALK |
RTK signaling |
49806720 |
974 |
266 |
20 |
293 |
Amuvatinib |
MP470, MP 470, MP-470 |
KIT, PDGFRA, FLT3 |
Other, kinases |
11282283 |
971 |
266 |
21 |
205 |
Avagacestat |
BMS-708163, BMS 708163 |
Amyloid beta20, Amyloid beta40 |
Other |
46883536 |
977 |
266 |
22 |
1072 |
Avagacestat |
BMS-708163, BMS 708163 |
Amyloid beta20, Amyloid beta40 |
Other |
46883536 |
957 |
266 |
23 |
1021 |
Axitinib |
AG-13736, Inlyta |
PDGFR, KIT, VEGFR |
RTK signaling |
6450551 |
877 |
266 |
24 |
178 |
BAY-61-3606 |
Syk Inhibitor, BAY-613606 |
SYK |
Other, kinases |
10200390 |
925 |
266 |
25 |
60 |
BI-2536 |
|
PLK1, PLK2, PLK3 |
Cell cycle |
11364421 |
424 |
266 |
26 |
279 |
BIX02189 |
BIX 02189 |
MEK5, ERK5 |
ERK MAPK signaling |
46931012 |
975 |
266 |
27 |
203 |
BMS-345541 |
BMS345541, IKK Inhibitor 3 |
IKK1, IKK2 |
Other, kinases |
9813758 |
980 |
266 |
28 |
63 |
BMS-509744 |
KIN001-127, ITK inhibitor |
ITK |
Other |
20635522 |
426 |
266 |
29 |
62 |
BMS-536924 |
BMS 536924 |
IGF1R, IR |
IGFR signaling |
10390396 |
425 |
266 |
30 |
1091 |
BMS-536924 |
BMS 536924 |
IGF1R, IR |
Unclassified |
10390396 |
956 |
266 |
31 |
184 |
BMS-754807 |
BMS754807, BMS 754807 |
IGF1R, IR |
IGFR signaling |
24785538 |
924 |
266 |
32 |
222 |
BX-912 |
|
PDK1 (PDPK1) |
PI3K/MTOR signaling |
11754511 |
978 |
266 |
33 |
1037 |
BX795 |
BX-795 |
TBK1, PDK1 (PDPK1), IKK, AURKB, AURKC |
Other |
10077147 |
878 |
266 |
34 |
274 |
Belinostat |
PXD101, PXD-101 |
HDAC1 |
Chromatin histone acetylation |
6918638 |
948 |
266 |
35 |
186 |
Bexarotene |
LG-100069, Targretin, Targret, Targrexin, Targretyn, Bexarotenum |
Retinioic X receptor (RXR) agonist |
Other |
82146 |
917 |
266 |
36 |
150 |
Bicalutamide |
ICI-176334, Casodex, Cosudex, ICI 176334 |
AR |
Hormone-related |
2375 |
927 |
266 |
37 |
1502 |
Bicalutamide |
ICI-176334, Casodex, Cosudex, ICI 176334 |
AR |
Hormone-related |
2375 |
903 |
266 |
38 |
190 |
Bleomycin |
|
dsDNA break induction |
DNA replication |
several |
920 |
266 |
39 |
1378 |
Bleomycin |
|
dsDNA break induction |
DNA replication |
5460769 |
965 |
266 |
40 |
104 |
Bortezomib |
PS-341, LDP-341, Velcade |
Proteasome |
Protein stability and degradation |
387447 |
426 |
266 |
41 |
1019 |
Bosutinib |
SKI-606, Bosulif |
SRC, ABL, TEC |
Other, kinases |
5328940 |
883 |
266 |
42 |
197 |
Bryostatin 1 |
Bryostatin |
PKC |
Other, kinases |
5280757 |
923 |
266 |
43 |
276 |
CAY10603 |
|
HDAC1, HDAC6 |
Chromatin histone acetylation |
24951314 |
968 |
266 |
44 |
1170 |
CCT-018159 |
CCT018159, CCT 018159 |
HSP90 |
Protein stability and degradation |
5327091 |
929 |
266 |
45 |
1067 |
CCT007093 |
|
PPM1D |
Other |
2314623 |
952 |
266 |
46 |
54 |
CGP-082996 |
CINK4, KIN001-021 |
CDK4 |
Cell cycle |
24825971 |
425 |
266 |
47 |
53 |
CGP-60474 |
KIN001-019, CGP60474, CGP 60474 |
CDK1,CDK2,CDK5,CDK7,CDK9, PKC |
Cell cycle |
644215 |
425 |
266 |
48 |
154 |
CHIR-99021 |
CT 99021, CHIR99021, CHIR 99021 |
GSK3A, GSK3B |
WNT signaling |
9956119 |
935 |
266 |
49 |
1241 |
CHIR-99021 |
CT 99021, CHIR99021, CHIR 99021 |
GSK3A, GSK3B |
WNT signaling |
9956119 |
944 |
266 |
50 |
1015 |
CI-1040 |
CI 1040, PD-18435, PD-184352, 212631-79-3 |
MEK1, MEK2 |
ERK MAPK signaling |
6918454 |
871 |
266 |
51 |
64 |
CMK |
KIN001-128 |
RSK2 |
ERK MAPK signaling |
16663089 |
425 |
266 |
52 |
152 |
CP466722 |
CP-466722, CP 466722, 1080622-86-1 |
ATM |
Genome integrity |
44551660 |
980 |
266 |
53 |
255 |
CP724714 |
CP-724714 |
ERBB2 |
EGFR signaling |
9874913 |
977 |
266 |
54 |
273 |
CUDC-101 |
CUDC 101 |
HDAC1-10, EGFR, ERBB2 |
Other |
24756910 |
957 |
266 |
55 |
300 |
CX-5461 |
CX5461, CX 5461 |
RNA Polymerase 1 |
Other |
25257557 |
971 |
266 |
56 |
249 |
Cabozantinib |
BMS-907351, XL-184, Cometriq |
VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL |
Other, kinases |
25102847 |
975 |
266 |
57 |
1114 |
Cetuximab |
Erbitux, IMC-C225, C225, IMC-225, L01XC06 |
EGFR |
EGFR signaling |
85668777 |
899 |
266 |
58 |
1005 |
Cisplatin |
cis-Diammineplatinum(II) dichloride, Platinol, CIS-DDP |
DNA crosslinker |
DNA replication |
84691 |
882 |
266 |
59 |
37 |
Crizotinib |
Xalkori, PF2341066, PF-2341066, PF 2341066 |
MET, ALK, ROS1 |
RTK signaling |
11626560 |
433 |
266 |
60 |
17 |
Cyclopamine |
|
SMO |
Other |
several |
421 |
266 |
61 |
1006 |
Cytarabine |
Ara-Cytidine, Arabinosyl Cytosine, U-19920 |
Antimetabolite |
DNA replication |
6253 |
878 |
266 |
62 |
165 |
DMOG |
Dimethyloxalylglcine |
HIF-PH |
Metabolism |
560326 |
934 |
266 |
63 |
1373 |
Dabrafenib |
GSK2118436, Tafinlar |
BRAF |
ERK MAPK signaling |
44462760 |
899 |
266 |
64 |
200 |
Dacinostat |
NVP-LAQ824, LAQ824 |
HDAC1 |
Chromatin histone acetylation |
6445533 |
929 |
266 |
65 |
1057 |
Dactolisib |
NVP-BEZ235, BEZ235 |
PI3K (Class 1), MTORC1, MTORC2 |
PI3K/MTOR signaling |
11977753 |
871 |
266 |
66 |
1248 |
Daporinad |
APO866, FK866, FK866 |
NAMPT |
Metabolism |
6914657 |
930 |
266 |
67 |
51 |
Dasatinib |
BMS-354825-03, BMS-354825, Sprycel |
ABL, SRC, Ephrins, PDGFR, KIT |
Other |
3062316 |
422 |
266 |
68 |
1007 |
Docetaxel |
RP-56976, Taxotere |
Microtubule stabiliser |
Mitosis |
148124 |
882 |
266 |
69 |
1042 |
Doramapimod |
BIRB-796, BIRB 796 |
p38, JNK2 |
JNK and p38 signaling |
156422 |
867 |
266 |
70 |
133 |
Doxorubicin |
Doxil, Rubex, Adriamycin, Adriablastin, Doxorubicine |
Anthracycline |
DNA replication |
31703 |
928 |
266 |
71 |
1069 |
EHT-1864 |
EHT 1864 |
RAC1, RAC2, RAC3 |
Cytoskeleton |
9938202 |
955 |
266 |
72 |
1031 |
Elesclomol |
STA-4783 |
HSP90 |
Protein stability and degradation |
300471 |
881 |
266 |
73 |
172 |
Embelin |
Emberine, Embelic acid |
XIAP |
Apoptosis regulation |
3218 |
929 |
266 |
74 |
88 |
Entinostat |
MS-275 |
HDAC1, HDAC3 |
Chromatin histone acetylation |
4261 |
427 |
266 |
75 |
229 |
Enzastaurin |
LY317615 |
PKCB |
Other, kinases |
176167 |
978 |
266 |
76 |
201 |
Epothilone B |
Patupilone, EpoB, EPO906, GNF-PF-193 |
Microtubule stabiliser |
Mitosis |
448013 |
928 |
266 |
77 |
1 |
Erlotinib |
Tarceva, RG-1415, CP-358774, OSI-774, Ro-508231, R-1415 |
EGFR |
EGFR signaling |
176870 |
392 |
266 |
78 |
134 |
Etoposide |
Etopophos, Vepesid, Eposin, VP-16 |
TOP2 |
DNA replication |
36462 |
936 |
266 |
79 |
173 |
FH535 |
|
PPARgamma, PPARdelta |
WNT signaling |
3463933 |
926 |
266 |
80 |
231 |
FMK |
KIN001-242 |
RSK |
Other, kinases |
none |
836 |
266 |
81 |
263 |
FR-180204 |
FR 180204, FR180204, ERK Inhibitor II |
ERK1, ERK2 |
ERK MAPK signaling |
11493598 |
975 |
266 |
82 |
166 |
FTI-277 |
|
Farnesyl-transferase (FNTA) |
Other |
3005532 |
937 |
266 |
83 |
306 |
Fedratinib |
TG101348, TG-101348, SAR302503, SAR-302503 |
JAK2 |
Other, kinases |
16722836 |
976 |
266 |
84 |
308 |
Foretinib |
GSK1363089, XL-880, EXEL-2880, GSK089 |
MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR |
RTK signaling |
42642645 |
972 |
266 |
85 |
52 |
GNF-2 |
KIN001-013 |
BCR-ABL |
ABL signaling |
5311510 |
423 |
266 |
86 |
226 |
GSK1070916 |
GSK-1070916 |
AURKA, AURKC |
Mitosis |
46885626 |
950 |
266 |
87 |
202 |
GSK1904529A |
GSK-1904529A, GSK 1904529A |
IGF1R, IR |
IGFR signaling |
25124816 |
928 |
266 |
88 |
127 |
GSK269962A |
GSK 269962A |
ROCK1, ROCK2 |
Cytoskeleton |
16095342 |
429 |
266 |
89 |
1192 |
GSK269962A |
GSK 269962A |
ROCK1, ROCK2 |
Cytoskeleton |
16095342 |
958 |
266 |
90 |
91 |
GSK319347A |
KIN001-135, IKK-3 inhibitor |
IKK |
Other |
11626927 |
428 |
266 |
91 |
230 |
GSK429286A |
|
ROCK1, ROCK2 |
Cytoskeleton |
11373846 |
980 |
266 |
92 |
177 |
GSK650394 |
GSK-650394, GSK 650394 |
SGK2, SGK3 |
Other |
25022668 |
920 |
266 |
93 |
326 |
GSK690693 |
GSK 690693, GSK-690693 |
AKT1, AKT2, AKT3 |
PI3K/MTOR signaling |
16725726 |
975 |
266 |
94 |
193 |
GW-2580 |
GX2580, CFMS receptor tyrosine kinase inhibitor |
CSF1R |
RTK signaling |
11617559 |
977 |
266 |
95 |
1023 |
GW441756 |
GW 441756 |
NTRK1 |
RTK signaling |
9943465 |
879 |
266 |
96 |
87 |
GW843682X |
GW843682X (AN-13) |
PLK1 |
Cell cycle |
9826308 |
426 |
266 |
97 |
1010 |
Gefitinib |
ZD-1839, Iressa |
EGFR |
EGFR signaling |
123631 |
878 |
266 |
98 |
135 |
Gemcitabine |
Gemzar, LY-188011 |
Pyrimidine antimetabolite |
DNA replication |
60750 |
923 |
266 |
99 |
225 |
Genentech Cpd 10 |
|
AURKA, AURKB |
Mitosis |
none |
980 |
266 |
100 |
1142 |
HG-5-113-01 |
|
LOK, LTK, TRCB, ABL(T315I) |
Other |
none |
512 |
266 |